Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug-Drug Interactions

Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract

(2013) Filippo Caraci et al.   CURRENT DRUG METABOLISM

Herb-Drug Interactions and Mechanistic and Clinical Considerations

(2012) Xiao-Wu Chen et al.   CURRENT DRUG METABOLISM

An update on the ability of St. John's wort to affect the metabolism of other drugs

(2012) Roja Rahimi et al.   Expert Opinion on Drug Metabolism & Toxicology

Interactions between Herbs and Conventional Drugs: Overview of the Clinical Data

(2012) Angelo A. Izzo   MEDICAL PRINCIPLES AND PRACTICE

Effects ofHypericum montbrettiExtract on the Central Nervous System and Involvement of GABA (A)/Benzodiazepine Receptors in its Pharmacological Activity

(2012) Özgür Devrim Can et al.   PHYTOTHERAPY RESEARCH

Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice

(2011) Rosalia Crupi et al.   BMC Complementary and Alternative Medicine

Clinical Herbal Interactions with Conventional Drugs: From Molecules to Maladies

(2011) X.-W. Chen et al.   CURRENT MEDICINAL CHEMISTRY

Effects of treatment with St. John's Wort on blood glucose levels and pain perceptions of streptozotocin-diabetic rats

(2011) Özgür Devrim Can et al.   FITOTERAPIA

Interaction of St John’s wort (Hypericum perforatum) with clozapine

(2011) Annelies C.P. Van Strater et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

St. Johns Wort Components and the Brain: Uptake, Concentrations Reached and the Mechanisms Underlying Pharmacological Effects

(2010) Silvio Caccia et al.   CURRENT DRUG METABOLISM

Neurobiological Effects of Hyperforin and its Potential in Alzheimers Disease Therapy

(2010) T. Griffith et al.   CURRENT MEDICINAL CHEMISTRY

St John's wort greatly reduces the concentrations of oral oxycodone

(2010) Tuija H. Nieminen et al.   EUROPEAN JOURNAL OF PAIN

Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression

(2010) Siegfried Kasper et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Drug interaction between St John’s wort and zolpidem in healthy subjects

(2010) Y. Hojo et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

A review of the antibacterial activity of Hypericum perforatum L.

(2010) Zeb Saddiqe et al.   JOURNAL OF ETHNOPHARMACOLOGY

St. John’s Wort Constituents Modulate P-glycoprotein Transport Activity at the Blood-Brain Barrier

(2010) Melanie Ott et al.   PHARMACEUTICAL RESEARCH

Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations

(2009) Francesca Borrelli et al.   AAPS Journal

Photosensitivity associated with selective serotonin reuptake inhibitors

(2009) V. Doffoel-Hantz et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

Interactions Between Herbal Medicines and Prescribed Drugs

(2009) Angelo A. Izzo et al.   DRUGS

St John’s wort extract (Ze 117) does not alter the pharmacokinetics of a low-dose oral contraceptive

(2009) Liane Will-Shahab et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Evaluation ofHypericum perforatumoil extracts for an antiinflammatory and gastroprotective activity in rats

(2009) G. Zdunić et al.   PHYTOTHERAPY RESEARCH

Evaluating the safety of St. John's Wort in human pregnancy

(2009) Myla E. Moretti et al.   REPRODUCTIVE TOXICOLOGY

The recovery time-course of CYP3A after induction by St John's wort administration

(2008) Hiromitsu Imai et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Triptans and Serotonin Syndrome

(2008) RW Evans   CEPHALALGIA

An Update on Clinical Drug Interactions with the Herbal Antidepressant St. Johns wort

(2008) Shu-Feng Zhou et al.   CURRENT DRUG METABOLISM

Clinical Drugs that Interact with St. Johns Wort and mplication in Drug Development

(2008) Yuan Di et al.   CURRENT PHARMACEUTICAL DESIGN

No clinically relevant CYP3A induction after St. John’s wort with low hyperforin content in healthy volunteers

(2008) Silke C. Mueller et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Continuation and long-term maintenance treatment with Hypericum extract WS® 5570 after recovery from an acute episode of moderate depression — A double-blind, randomized, placebo controlled long-term trial

(2008) S. Kasper et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation

(2008) Stephen Bent   JOURNAL OF GENERAL INTERNAL MEDICINE

Efficacy and tolerability of Hypericum perforatum in major depressive disorder in comparison with selective serotonin reuptake inhibitors: A meta-analysis

(2008) Roja Rahimi et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition

(2008) S.-F. Zhou   XENOBIOTICA